Star Health & Allied Insurance Company's Stock Hits 52-Week Low, Given 'Strong Sell' Call by MarketsMOJO

Nov 11 2024 09:50 AM IST
share
Share Via
Star Health & Allied Insurance Company, a leading insurance company in the finance/NBFC industry, saw a -3.19% decline in its stock price on November 11, 2024, closing at Rs. 465, its new 52-week low. According to MarketsMojo, the stock has been given a 'Strong Sell' call and has underperformed the sector by -3.09%. It has also been trading below all its moving averages, indicating a downward trend. In comparison to the overall market, the stock has underperformed with a -2.56% 1-day performance and a -14.35% 1-month performance. Investors and experts are advised to closely monitor the stock's performance in the coming days.

Star Health & Allied Insurance Company, a leading insurance company in the finance/NBFC industry, has seen a decline in its stock price. On November 11, 2024, the company's stock lost -3.19%, closing at Rs. 465. This is also the new 52-week low for the company.

According to MarketsMOJO, a leading stock market analysis platform, the stock has been given a 'Strong Sell' call. The stock has also underperformed the sector by -3.09% on the same day.

This is the second consecutive day of decline for Star Health & Allied Insurance Company, with a total fall of -6.71% in the past two days. The stock touched an intraday low of Rs. 465, a decrease of -3.45%.

The moving averages for the company show that it is currently trading below the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a downward trend in the stock's performance.

In comparison to the overall market performance, Star Health & Allied Insurance Company has underperformed. On the same day, the stock's 1-day performance was -2.56%, while the Sensex's performance was 0.11%. Similarly, the stock's 1-month performance was -14.35%, while the Sensex's performance was -2.22%.

Investors and experts are advised to closely monitor the performance of Star Health & Allied Insurance Company in the coming days. This is not a recommendation to buy or sell the stock, but rather a fact-based update on its recent performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News